Investing
The round brings the virtual care company's total raise to $205 million.
The company utilizes machine learning and patient data to deliver personalized medication management pertaining to polypharmacy.
It expects continued long-term growth in the demand for virtual care services post-pandemic.
The company will use the investment to fuel the expansion of Paradigm,its FDA-cleared, AI-enabled surgical navigation platform.
The multiple sclerosis-focused company will use the funds to speed up the company's commercialization efforts.
GenHealth AI, maker of what it calls a large medical model, and senior-focused startup K4Connnect also secured investment.
Mental health company UpLift and electrophysiology-focused medical technology company CathVision also garnered investment.
The senior debt facility is part of Amino's $80 million in equity and debt financing received in May.
The round brings the company's total raise to $93 million.
The company will use the funds to speed up its growth.